Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1012 of 5804
-
Specialist dream team takes on heart disease and diabetes
Disease control Not yet recruitingThis project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver docto…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Coil treatment may prevent brain bleed recurrence
Disease control Recruiting nowThis is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug duo aims to halt rare sarcomas
Disease control Recruiting nowTo learn if zanzalintinib and pembrolizumab can help to control select subtypes of advanced/metastatic soft-tissue sarcoma (UPS, MFS, HGPS, and HGUS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a common gout pill save legs and lives?
Disease control Recruiting nowChronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease, a condition in which narrowed or blocked arteries reduce blood flow to the legs. People with CLTI may have severe leg pain at rest, non-healing wounds, or gangrene, and face a high risk…
Phase: PHASE3 • Sponsor: Shin Kong Wu Ho-Su Memorial Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New shot for eczema shows promise in large trial
Disease control Recruiting nowThis study is an open label, prospective study to evaluate the safety and efficacy of Stapokibart Injection in patients with AD.
Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Scientists test RSV vaccine to boost immune memory
⭐️ VACCINE ⭐️ Not yet recruitingThe purpose of this study is to elucidate the molecular mechanism by which novel adjuvants enhance the immunogenicity of Respiratory Syncytial Virus (RSV) vaccines by regulating antigen-specific B cell affinity maturation and T cell memory formation.
Phase: NA • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New antibody WIN378 aims to tame COPD lung inflammation
Disease control Recruiting nowThis study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease (COPD). WIN378 blocks the action of a protein called TSLP that causes inflammation in the lung and may contribute to COP…
Phase: PHASE2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Talking it out in the ICU may stop PTSD after heart surgery
Prevention Recruiting nowThis clinical trial aims to evaluate whether an ICU-based preventive narrative exposure intervention can help prevent posttraumatic stress symptoms in adult patients after cardiac surgery with cardiopulmonary bypass. The study will include adult patients who undergo cardiac surg…
Phase: NA • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
Virtual stenting tech aims to improve heart artery procedures
Disease control Recruiting nowCoronary angiography-guided percutaneous coronary intervention (PCI) remains the standard treatment strategy for patients with coronary artery disease; however, suboptimal post-PCI physiological outcomes remain common and are associated with adverse cardiovascular prognosis. Quan…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple drug during brain surgery prevent Life-Threatening sodium swings?
Disease control ENROLLING_BY_INVITATIONCraniopharyngiomas and giant invasive pituitary adenomas, with lesions originating from the pituitary stalk, are frequently associated with intraoperative and postoperative diabetes insipidus (DI). DI can lead to hypernatremia, and the rapid elevation of serum sodium within hours…
Phase: PHASE4 • Sponsor: Zhaoyun Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Five sessions to save lives: new therapy targets suicidal teens
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the Ultra-Brief Interpersonal Psychotherapy for Adolescents with Suicidal Ideation (IPT-A-SCI) works to reduce suicidal thoughts and behaviors in children and adolescents. The study will also examine whether treatment effects continu…
Phase: NA • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
AI app aims to ease chemo side effects for breast cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if an Arabic-language mobile application that uses artificial intelligence (AI) can help women with breast cancer during chemotherapy. The app is designed to give personalized support by reminding participants about their medications, t…
Phase: NA • Sponsor: Dena h. Al-Tameemi • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Could a tiny ear device ease severe PMS and menopause symptoms?
Symptom relief Recruiting nowTranscutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the in…
Phase: NA • Sponsor: Texas Christian University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New shot aims to reverse liver scarring in MASH patients
Disease control Not yet recruitingThis is a Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial to evaluate efficacy and safety of QL2401 in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis (F2-F3).
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could stem cells help people with spinocerebellar ataxia?
Disease control Not yet recruitingThis clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes…
Phase: PHASE1, PHASE2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a simple inhaled antibiotic stop deadly pneumonia in ventilator patients?
Disease control Not yet recruitingThe primary objective of the AMIVAT trial is to assess whether a 5-day course of inhaled amikacin, compared to placebo, reduces the incidence of progression to ventilator-associated pneumonia (VAP) at day 28 in intensive care unit (ICU) patients with ventilator-associated tracheo…
Phase: PHASE3 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New scan could sharpen breast cancer staging
Diagnosis Not yet recruitingThis study aims to evaluate the clinical utility of \[68Ga\]Ga-FAP-2268 PET/CT for disease staging and assessment in patients with high-risk primary breast cancer. By targeting fibroblast activation protein (FAP), this novel imaging approach may offer improved tumor visualization…
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Robot doctor navigates lungs to spot cancer
Diagnosis Not yet recruitingThis is a single-center, prospective, and single-arm study. The purpose of this study is to evaluate the feasibility and safety of a new self-driving robotic-assisted bronchoscopic system for the diagnosis of peripheral pulmonary nodules.
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
No-Needle breast MRI: AI could replace contrast dye for cancer detection
Diagnosis Not yet recruitingThis study is conducted under the ethics-approved project titled "Artificial Intelligence Solution for Simplifying the Diagnostic Workflow of Breast MRI''.The goal of this observational study is to develop an integrated breast MRI system that uses diffusion-weighted imaging (DWI)…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Could insulin eye drops save your sight? new trial launches
Disease control Not yet recruitingThis study evaluates the safety and preliminary efficacy of topical sterile human insulin eye drops (EYED-002) in patients with open-angle glaucoma. The study uses a phase 1/2 dose-escalation design followed by a masked, randomized, placebo-controlled phase. Insulin is formulated…
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC